Tamhankar Ashwin Sunil, Thurtle David, Hampson Alexander, El-Taji Omar, Thurairaja Ramesh, Kelly John D, Catto James W F, Lane Tim, Adshead James, Vasdev Nikhil
Hertfordshire and Bedfordshire Urological Cancer Centre Lister Hospital Stevenage UK.
Department of Urology Guys Hospital London UK.
BJUI Compass. 2021 Mar 12;2(5):338-347. doi: 10.1002/bco2.79. eCollection 2021 Sep.
We evaluate the data of 12,644 Radical Cystectomies in England (Open, Robotic and Laparoscopic) with trends in the adaption of techniques and post-operative complications.
This analysis utilised national Hospital Episode Statistics (HES) from NHS England.
There was a statistically significant increase ( < .001) in the number of Robotic assisted radical cystectomies from 10.8% in 2013-2014 and 39.5% in 2018-2019.The average LOS reduced from 12.3 to 10.8 days for RARC from 2013 to 2019 similarly the LOS reduced from 16.2 to 14.3 for ORC. The rate of sepsis (0-90 days) did rise from 5% to 14.5% between 2013-2014 and 2017-2018 for the entire cohort ( < .001). Acute renal failure (ARF) increased over the years from 9.5% to 17% ( < .001). The rate for fever, UTI, critical care activity and ARF were higher for ORC than RARC ( < .001).The comparison of all episodes within 90 days for conduit versus non-conduit diversions showed significantly higher rates of sepsis, infections, UTI and fever in non-conduit group .Overall complications were significantly higher in non-conduit group throughout the duration except was year 2016-17( < .001).The robotic approach has increased in last 5 years with nearly 40% of the cystectomies now being robotically in 2018-19 from the initial percentage of 10.8% in 2013-14.
This evaluation of the HES data from NHS England for 12,644 RC confirms an increase in the adoption of Robotic Cystectomy. Our data confirms the need to develop strategies with enhanced recovery protocols and post-operative close monitoring following Radical Cystectomy in order to reduce post-operative complications.
我们评估了英格兰12644例根治性膀胱切除术(开放、机器人辅助和腹腔镜手术)的数据,以及技术应用趋势和术后并发症情况。
本分析使用了英国国民医疗服务体系(NHS)英格兰地区的国家医院住院统计数据(HES)。
机器人辅助根治性膀胱切除术的数量从2013 - 2014年的10.8%显著增加至2018 - 2019年的39.5%(P <.001)。2013年至2019年,机器人辅助根治性膀胱切除术的平均住院时间从12.3天降至10.8天,同样,开放根治性膀胱切除术的平均住院时间从16.2天降至14.3天。在2013 - 2014年至2017 - 2018年期间,整个队列的脓毒症发生率(0 - 90天)从5%上升至14.5%(P <.001)。急性肾衰竭(ARF)多年来从9.5%增加至17%(P <.001)。开放根治性膀胱切除术的发热、尿路感染、重症监护活动和急性肾衰竭发生率高于机器人辅助根治性膀胱切除术(P <.001)。对90天内导管改道与非导管改道的所有病例进行比较,结果显示非导管改道组的脓毒症、感染、尿路感染和发热发生率显著更高。除2016 - 17年外,非导管改道组在整个观察期内的总体并发症发生率显著更高(P <.001)。在过去5年中,机器人手术方式有所增加,2018 - 19年机器人辅助膀胱切除术占比近40%,而2013 - 14年这一比例为10.8%。
对英国国民医疗服务体系(NHS)英格兰地区12644例根治性膀胱切除术的HES数据进行的评估证实了机器人辅助膀胱切除术的应用有所增加。我们的数据证实,有必要制定策略,采用强化康复方案并在根治性膀胱切除术后进行密切监测,以减少术后并发症。